Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:51 PM
Ignite Modification Date:
2025-12-24 @ 10:51 PM
NCT ID:
NCT03046069
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of COPD, self-reported.
* Age: More than or equal to 40 years.
* Moderate to severe COPD, indicated by a COPD Assessment Test (CAT) score of greater than or equal to 10 or Modified Medical Research Council (MMRC) score of greater than or equal to 2.
* Currently prescribed and receiving one of the following treatment types: ICS/LABA; LABA/LAMA; ICS/LABA/LAMA (triple therapy); LAMA.
* Currently resident in the UK, US or Germany.
* Adequate written and oral fluency in language of country of residence.
* Willing and able to understand the study and provide informed consent.
* Has access to the internet (Cognitive interviews and DCE survey only).
Exclusion Criteria:
* Has taken part in any other stage of this study.
* Subjects with a current diagnosis of asthma. (Subjects with a prior history of asthma are eligible if they have a current diagnosis of COPD).
* Any co-morbidity that would inhibit the ability to provide informed consent or allow participation in a telephone of face-to-face interview.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Study:
NCT03046069
Study Brief:
Protocol Section:
NCT03046069